The pharma chain giant recently engaged strategic advisors about possibly breaking off its insurance and retail business.

Kezar Life Sciences halted its PALIZADE Phase 2b lupus nephritis trial due to fatal adverse events. Meanwhile, its PORTOLA Phase 2a autoimmune hepatitis trial progresses, with topline data expected in ...

Shares of Navratna PSU Mazagon Dock Shipbuilders surged nearly 10 per cent in today’s trading session so far. As per BSE ...

General Motors has officially become America's second-best-selling EV maker behind Tesla, pushing Hyundai Motor Group into ...

Rights Apr 13, 2023 Apr 14, 2023 Dec 09, 2022 Rights ratio: 10 share for every 211 held at a price of Rs 140.0 Rights Dec 31, 2021 Jan 03, 2022 Jul 20, 2021 Rights ratio: 1 share for every 13 held at ...

Bajaj Auto share price has seen a sharp fall recently as the auto stock plunged over 13% in one month. However, Bajaj Auto ...

According to market observers, shares of the company are available at a premium of ₹1,426 in the grey market today ...

Harry Styles, Zayn Malik, Niall Horan and Louis Tomlinson of One Direction jointly and separately shared remembrances of ...

Ellwood City's undefeated run continues, OLSH's senior quarterback does a little of everything. All that and more in this ...

Mid-America Apartment Communities currently trades at a compelling level of about 19.5 times its adjusted FFO, and at current ...

Reliance Industries (RIL) has set the record date for its 1:1 bonus share issue. Post-issue, RIL's authorized share capital ...

Discover the best growth stocks for the next decade. Explore top investment opportunities with high growth potential to help ...